USPTO serial 76033877
CRYSTALOMICS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BELL, MARLENE D
- Law office
- DIVISIONAL UNIT
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CRYSTALOMICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christopher K. Barry-Smith
CHRISTOPHER K BARRY-SMITH BROMBERG & SUNSTEIN125 SUMMER ST STE 1100BOSTON, MA 02110-1618UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Proteins and chemicals, namely, antibodies, enzymes, glycoproteins, hormones and peptides, for general industrial and manufacturing and scientific, medical and agricultural purposes | ACTIVE | — |
| 005 | Proteins and chemicals, namely, antibodies, enzymes, glycoproteins, hormones and peptides for medical and veterinary clinical and diagnostic use and proteins and chemicals, namely antibodies, enzymes, glycoproteins, hormones and peptides for medical and therapeutic use in the treatment of infectious and parasitic diseases, neoplasms, endocrine diseases, nutritional deficiencies, metabolic diseases and disorders, immunity disorders, diseases of the blood and blood-forming organs, diseases and disorders of the circulatory system, diseases and disorders of the respiratory system, diseases and disorders of the digestive system, diseases and disorders of the genitourinary system, diseases and conditions of the skin and subcutaneous tissue, diseases and disorders of the muskoskeletal system and connective tissue, congenital anomalies, injuries, and poisoning, in humans, livestock, domestic pets and exotic animals | ACTIVE | — |
| 040 | Manufacture, modification and design of proteins and chemicals for others for general industrial and manufacturing use, medical and veterinary clinical, diagnostic and therapeutic use, and for use in scientific fields, the medical field, and the food, pharmaceutical and agricultural industries | ACTIVE | — |
| 042 | Research, development, design and testing of proteins and chemicals for others; providing technical advice and consultation services in the field of chemistry | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Altus Biologics Inc.
- Other trademarks owned by Altus Biologics Inc.
- Other trademarks owned by ALTUS PHARMACEUTICALS INC.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named CRYSTALOMICS
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 10, 2005 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 10, 2005 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 30, 2004 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Sep 15, 2004 | PAPER RECEIVED | — | |
| Sep 12, 2004 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jul 21, 2004 | CFIT | CASE FILE IN TICRS | — |
| Mar 25, 2004 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Mar 15, 2004 | PAPER RECEIVED | — | |
| Mar 11, 2004 | EXT4 | SOU EXTENSION 4 FILED | — |
| Nov 12, 2003 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Sep 15, 2003 | PAPER RECEIVED | — | |
| Sep 11, 2003 | EXT3 | SOU EXTENSION 3 FILED | — |
| Aug 28, 2003 | FAXX | FAX RECEIVED | — |
| May 15, 2003 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Mar 14, 2003 | PAPER RECEIVED | — | |
| Mar 12, 2003 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 28, 2002 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 29, 2002 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 29, 2002 | PAPER RECEIVED | — | |
| Mar 12, 2002 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 18, 2001 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 28, 2001 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 5, 2001 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 29, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 17, 2001 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 25, 2000 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 21, 2000 | DOCK | ASSIGNED TO EXAMINER | — |